What is BLRX's gross margin?

BioLineRx (BLRX) has a gross margin of 53% and a net margin of -1029%.

What is BLRX's P/E ratio?

Track BioLineRx (BLRX) P/E ratio, ROE, and valuation metrics over time.

Where can I see BLRX's full financials?

See BioLineRx (BLRX) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

BioLineRx (BLRX) Financials — Revenue, Earnings, Cash Flow

Also trades as: BLRX.TA (TLV) · $vol 0M

$2.37

+0.02 (+0.85%)

Weekly Expected Move ±6.1%

$2 $2 $2 $3 $3

NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 26 · $10.3M mcap · 4M float · 0.552% daily turnover · Short 23% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$1M

Revenue

-94.3% YoY

$-11M

Net Income

-223.5% YoY

$-9M

Free Cash Flow

+72.3% YoY

53.4%

Gross Margin

-1215.3%

Op. Margin

-1029.3%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-63.5%

ROA-28.6%

ROIC-113.0%

Valuation

P/E-1.4

P/B0.8

EV/EBITDA-0.8

Leverage

Debt/Equity0.58

Current Ratio1.20

Interest Cov.-11.4x

Quality Scores

Piotroski F3/9

Altman Z-17.48

Beneish M-2.53